EPO and Iron deficiency anemia: Injection of recombinant human EPO in mice resulted in increased Fgf23 mRNA and cFgf23, but only marginally increased iFgf23, indicating that production and cleavage of FGF23 are directly linked, as observed in inflammation and iron deficiency (102, 103).